Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03818724Unknown

Treatment Success With the CoolLoop Cryoablation System

Role: lead

NCT04845750Not ApplicableUnknown

The RODEO Micro Mapping Catheter in Cryoablation Procedures

Role: lead

NCT02553239Not ApplicableTerminated

CoolLoop Paroxysmal Atrial Fibrillation

Role: lead

NCT01687036Not ApplicableCompleted

Cryoablation of Atrial Fibrillation Using a Novel Cryoablation System

Role: lead

All 4 trials loaded